| Serial Number | 90833550 |
| Word Mark | TERPSIS STUDY |
| Filing Date | Friday, July 16, 2021 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Thursday, June 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 3, 2022 |
| Goods and Services | Providing medical information; providing medical information relating to therapies and treatments for anhedonia, major depressive disorder and mood disorders |
| NOT AVAILABLE | "STUDY" |
| Goods and Services | Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders, and evaluating epidemiological results for treatments for anhedonia, major depressive disorder and mood disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for anhedonia, major depressive disorder and mood disorders |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 20, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 20, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Event Date | Event Description |
| Tuesday, July 20, 2021 | NEW APPLICATION ENTERED |
| Monday, September 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 21, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, September 29, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 29, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 29, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, March 27, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, March 27, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 28, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 29, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 30, 2022 | ASSIGNED TO LIE |
| Thursday, March 31, 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, April 13, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 3, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 3, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 28, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, October 14, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, October 14, 2022 | SOU EXTENSION 1 FILED |
| Friday, October 14, 2022 | SOU EXTENSION 1 GRANTED |
| Tuesday, October 18, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 16, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, June 16, 2023 | SOU EXTENSION 2 FILED |
| Friday, June 16, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, June 20, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 19, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 19, 2023 | SOU EXTENSION 3 FILED |
| Tuesday, December 19, 2023 | SOU EXTENSION 3 GRANTED |
| Thursday, December 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 13, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 13, 2024 | SOU EXTENSION 4 GRANTED |
| Thursday, June 13, 2024 | SOU EXTENSION 4 FILED |